Tiny Health: Pediatric Microbiome Analysis
The first 1,000 days of life dictate the foundational trajectory of the human microbiome. Tiny Health is the first clinical-grade test specifically calibrated for maternal and pediatric gut health.
Why Pediatric Testing is Different
Testing a six-month-old infant using adult baseline metrics (which Thorne or ZOE rely on) yields clinically useless data. An infant's gut is largely dominated by Bifidobacterium to digest breast milk oligosaccharides (HMOs); adult diversity levels would actually indicate pathology in a newborn. Tiny Health compares infant samples against age-specific pediatric databases.
Methodology & Clinical Focus
Using shotgun metagenomics, Tiny Health screens for over 120,000 microbes. Their primary clinical focus is identifying early markers for conditions linked to dysbiosis, such as:
- Eczema and Atopic Dermatitis: Tracking levels of B. infantis and inflammation markers.
- Colic and Reflux: Identifying overgrowths of gas-producing pathogens like Klebsiella.
- Food Allergies: Measuring the presence of SCFA-producing bacteria necessary for immune tolerance.
Actionability
If your infant was born via C-section or required early antibiotics, their microbiome colonization is disrupted. Tiny Health provides specific, actionable probiotic strain recommendations to re-seed the gut, often suggesting specific strains like B. infantis EVC001 if it is missing.
Final Verdict
For expectant mothers, infants, and toddlers, Tiny Health is fundamentally without peer in the consumer market. Do not use adult tests for pediatric cases.